The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

O.V. Zaytseva

Helmholtz National Medical Research Center of Eye Diseases;
A.I. Evdokimov Moscow State University of Medicine and Dentistry

N.V. Neroeva

Helmholtz National Medical Research Center of Eye Diseases

T.D. Okhotsimskaya

Helmholtz National Medical Research Center of Eye Diseases

E.V. Bobykin

Ural State Medical University

Anti-VEGF therapy for neovascular age-related macular degeneration: causes of incomplete response

Authors:

O.V. Zaytseva, N.V. Neroeva, T.D. Okhotsimskaya, E.V. Bobykin

More about the authors

Journal: Russian Annals of Ophthalmology. 2021;137(5): 152‑159

Views: 1598

Downloaded: 61


To cite this article:

Zaytseva OV, Neroeva NV, Okhotsimskaya TD, Bobykin EV. Anti-VEGF therapy for neovascular age-related macular degeneration: causes of incomplete response. Russian Annals of Ophthalmology. 2021;137(5):152‑159. (In Russ.)
https://doi.org/10.17116/oftalma2021137051152

Recommended articles:
Diagnosis and clinical features of non-exudative macu­lar neovascularization. Russian Annals of Ophthalmology. 2023;(1):138-146
Fari­cimab: from research to clinical practice. Russian Annals of Ophthalmology. 2023;(4):115-120
Drug resi­stance of dermatophytes: do we face the emergence of Indian variants of trichophytosis?. Russian Journal of Clinical Dermatology and Vene­reology. 2023;(2):141-146
Nimo­dipine in treatment of bipo­lar diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(12):20-26

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.